<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="56005">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02377050</url>
  </required_header>
  <id_info>
    <org_study_id>UAB NEO 013</org_study_id>
    <nct_id>NCT02377050</nct_id>
  </id_info>
  <brief_title>Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates</brief_title>
  <official_title>Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary hypothesis is that preterm infants who are less than or equal to 32 weeks
      gestation and weigh 1001-2500 grams at birth will have an increase in weight gain with a
      feeding goal of 180-200 ml/kg/day more than the commonly used feeding goal of 140-160
      ml/kg/day
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed trial is designed to test the primary hypothesis that in preterm infants
      weighing 1001-2500 grams at birth and who are less than or equal to 32 weeks gestation,
      feeding goals of 180-200 ml/kg/day will increase weight gain (g/k/day) from time of
      enrollment to discharge home or 36 weeks post-menstrual age (PMA)(whichever comes first)
      more than the commonly used feeding goal volume of 140-160 ml/kg/day (usual feeding goal).
      This is a pilot study to determine the safety of increased volumes of feedings as opposed to
      fortification of feedings.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight gain</measure>
    <time_frame>baseline to average 12 weeks of age</time_frame>
    <description>Average change in weight between baseline and 12 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mid arm circumference</measure>
    <time_frame>baseline to average 12 weeks of age</time_frame>
    <description>average change in mid arm circumference between baseline and 12 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length</measure>
    <time_frame>baseline to average 12 weeks of age</time_frame>
    <description>average change in length between baseline and 12 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Head circumference</measure>
    <time_frame>baseline to average 12 weeks of age</time_frame>
    <description>average change in head circumference between baseline and 12 weeks</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Body fat composition</measure>
    <time_frame>36 weeks or discharge</time_frame>
    <description>Percentage of body fat composition</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">224</enrollment>
  <condition>Infant Premature</condition>
  <arm_group>
    <arm_group_label>Higher Volume Feeding Goal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infants randomized to this group will have higher volume feeding goals of 180-200 ml/kg/day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Volume Feeding Goal</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Infants randomized to this group will have feeding goals of 140-160 ml/kg/day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Higher Volume Feeding Goal</intervention_name>
    <description>feeding volume goal of 180-200 ml/kg/day</description>
    <arm_group_label>Higher Volume Feeding Goal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inborn or outborn infants born at a gestational age of 32 weeks or less; Birthweight
             1001-2500; Feeding volume of at least 120 ml/kg/day; Enrolled prior to 28 days of age
             and prior to exceeding 32 weeks

        Exclusion Criteria:

          -  Hemodynamically significant patent ductus arteriosis; History of necrotizing
             enterocolitis Bell Stage II or greater; Known gastrointestinal or neurologic
             malformations; Prior or planned enrollment into the NICHD MILK Trial; Terminal
             illness or decision to withhold or limit support
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Month</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Waldemar A Carlo, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Colm Travers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ariel A Salas, MD</last_name>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Colm Travers, MD</last_name>
    <phone>205-934-4680</phone>
    <email>ctravers@peds.uab.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Waldemar A Carlo, MD</last_name>
    <phone>205-934-4680</phone>
    <email>wcarlo@peds.uab.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 15, 2017</lastchanged_date>
  <firstreceived_date>December 1, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Colm Travers</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Nutritional support</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
